The influence of beta2-receptor polymorphisms on Recovery of Heart failure (REHAB)

The influence of beta2-receptor polymorphisms on Recovery of Heart failure (REHAB) - REHAB

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON31894

Enrollment

200

Registered

2008-07-15

Start date

2008-02-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congestive heart failure systolic heart failure

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Recovered gruop: Patients with systolic heart failure who initially had a LVEF

Exclusion criteria

Exclusion criteria: 1. Diastolic heart failure 2. Congenital causes of heart failure

Design outcomes

Primary

Measure	Time frame
1. The difference in occurrence of beta2-receptor haplotypes between the recovered and the control group will serve as a primary outcome. 2. The difference in occurrence of beta2-receptor haplotypes in a good responders group versus a bad responders group. Good responders will be defined as a change in LVEF >15% and bad responders as a change in LVEF	—

Secondary

Measure	Time frame
Not applicable.	—

Countries

Netherlands

Outcome results